首页>
外国专利>
Use of heparin-binding domain of fibronectin for diagnosis and treatment of cancer
Use of heparin-binding domain of fibronectin for diagnosis and treatment of cancer
展开▼
机译:纤连蛋白的肝素结合结构域在癌症诊断和治疗中的应用
展开▼
页面导航
摘要
著录项
相似文献
摘要
The FNIII13 domain of fibronectin and smaller fragments thereof have a tumour cell proliferation inhibitory effect. Compositions are provided comprising fragments of fibronectin having the FNIII 13 domain and fragments thereof. A system comprising cells exposed to fibronectin and caused to proliferate by the presence of tenascin are used as an in vitro method for screening possible anti-tumour agents. Cell-free systems comprising a fibronectin ligand and tenascin are also employed for screening potential anti-tumour or anti-cancer agents. Test compounds are assayed for the ability to disrupt binding of the fibronectin ligand to tenascin. A further cell-free system additionally includes a syndecan molecule.
展开▼